Related Experiment Video
Updated: Jul 13, 2026
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice
S Takagi1, N Hayakawa, H Kimoto
1Department of Neurobiology and Therapeutics, Graduate School and Faculty of Pharmaceutical Sciences, The University of Tokushima, Tokushima, Japan.
Abstract:
We investigated the alteration of oligodendrocytes in comparison with that of astrocytes and microglia in the mouse striatum after MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropridine) treatment under the same conditions using Western blot analysis and Immunohistochemistry. In our Western blot analysis, four administrations of MPTP at 2-h intervals to mice produced the remarkable loss of TH (tyrosine hydroxylase) protein levels in the striatum after 3 and 7 days. In contrast, GFAP (glial fibrillary acidic protein) and Iba-1 protein in the striatum showed a significant increase of GFAP and Iba-1 protein levels 3 and 7 days after MPTP treatment. On the other hand, the levels of CNPase (2', 3'-cyclic nucleotide 3'-phosphodiesterase) protein were decreased significantly in the striatum 3 and 7 days after MPTP treatment. In our immunohistochemical study, a significant decrease in the area of expression of CNPase-positive profiles was observed in the striatum 3 and 7 days after MPTP treatment. These results demonstrate that oligodendrocytes in the striatum are damaged after MPTP treatment. Thus our present findings provide valuable information for the pathogenesis of Parkinson's disease.
Insights
MPTP treatment significantly damages oligodendrocytes in the mouse striatum, indicated by decreased CNPase protein. This contrasts with increased astrocyte and microglia markers, offering insights into Parkinson
Area of Science:
- Neuroscience
- Cell Biology
- Neurodegeneration
Background:
- Parkinson's disease pathogenesis involves dopaminergic neuron loss.
- The role of glial cells, including oligodendrocytes, astrocytes, and microglia, is crucial in neurodegenerative processes.
- MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropridine) is a common neurotoxin used to model Parkinson's disease.
Purpose of the Study:
- To investigate the specific alterations of oligodendrocytes compared to astrocytes and microglia in the mouse striatum following MPTP administration.
- To elucidate the impact of MPTP neurotoxicity on oligodendrocyte integrity and function.
- To provide insights into the cellular mechanisms underlying Parkinson's disease pathology.
Main Methods:
- Western blot analysis was employed to quantify protein levels of tyrosine hydroxylase (TH), glial fibrillary acidic protein (GFAP), Iba-1, and 2', 3'-cyclic nucleotide 5'-nucleotidase (CNPase).
- Immunohistochemistry was utilized to assess the spatial expression of CNPase-positive profiles in the striatum.
- Mice were administered MPTP at intervals to induce neurotoxicity, with tissue analysis conducted at 3 and 7 days post-treatment.
Main Results:
- MPTP treatment led to a significant reduction in TH protein levels, confirming dopaminergic neurotoxicity.
- GFAP and Iba-1 protein levels, markers for astrocytes and microglia respectively, were significantly increased, indicating reactive gliosis.
- A significant decrease in CNPase protein levels and reduced area of CNPase-positive profiles were observed, demonstrating damage to oligodendrocytes.
Conclusions:
- Oligodendrocytes in the mouse striatum are demonstrably damaged following MPTP treatment.
- The findings highlight a differential response of glial cell types to MPTP neurotoxicity.
- These results contribute valuable information regarding the pathogenesis of Parkinson's disease, emphasizing oligodendrocyte injury.
